Please login to the form below

Not currently logged in
Email:
Password:

inVentiv Health appoints head of commercial and consulting

Michael Griffith is former CEO of Laureate Biopharma
michael-griffith-inventiv

The life science services firm inVentiv Health has named Michael Griffith as executive VP in charge of the company's commercial and consulting businesses.

Griffith joins inVentiv Health from the contract manufacturing organisation Laureate Biopharma where he was CEO.

At inVentiv Health his responsibilities include Campbell Alliance, the biopharmaceutical management consulting firm; Adheris Health, the provider of patient adherence programmes; Chandler Chicco Companies, the healthcare communications firm and inVentiv Selling Solutions, the provider of outsourced clinical field and sales teams.

"inVentiv Health provides an opportunity for me to leverage all the skills I've acquired in finance, outsourcing, product development and commercialisation," said Griffith. "It is a pleasure to be working with a company built to change the game in the development and commercialisation of treatments that improve patient outcomes worldwide.

Griffith also founded and served as CEO of Aptuit and served as Chairman and CEO of ChiRex.

His background is financial, however, serving at both Bankers Trust Company and Credit Suisse First Boston.

11th April 2014

From: Research, Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics